1–10 of 17 results for vasculopathy
Presumed Polypoidal Choroidal Vasculopathy with Extensive Submacular Fibrosis and Recurrent Subretinal Hemorrhage
Pablo Angel García-Uribe, MD, PhD
Retina Image Bank: Images of the Week
2026
Intravitreal Aflibercept 8 mg in Patients With Polypoidal Choroidal Vasculopathy Phase 3 PULSAR Trial Subgroup Analysis
David T.W. Wong, MD, FRCS(C), FASRS
Annual Meeting Talks
2023
Expert Panel: Faricimab and Aflibercept 8 mg in AMD
John T. Thompson, MD
Andrew A. Moshfeghi, MD, MBA, FASRS
Manjot K Gill, MD, FASRS
Christina Y Weng, MD, MBA, FASRS
Ferhina S Ali, MD, MPH
Ian Pearce, MB ChB BSc FRCOPHTH
2024
Submacular Hemorrhage PCV
Shobhit Chawla, M.S.
2022
Choroidal Disturbance in Polypoidal Choroidal Vasculopathy: Insights From Dynamic Indocyanine Green Angiography
Gemmy Chui Ming Cheung, FRCOphth
Updates from the Field
Familial Retinal Arterial Macroaneurysms With Supravalvular Pulmonic Stenosis: A Syndrome With Life Threatening Potential You Should Not Miss
Sawsan R Nowilaty, MD, FASRS
On Demand Cases, Courses, and Papers
2020
Episcleral Brachytherapy for Exudative Macular Degeneration
Gregg T. Kokame, MD, MMM, FASRS
Branching vascular network..Polypoidal choroidal vasculopathy
Ophthalmic Manifestations Associated With SARSCoV-2 in Newborn Infants: A Preliminary Report
Maria Ana Martinez-Castellanos, MD
2021
Surgical Case Conference Aleksandra Rachitskaya
Aleksandra V. Rachitskaya, MD, FASRS
2019